Astrana Health ASTH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 10.7%-1.3pp | 10.7%-2.6pp | 10.3%-4.8pp | 11.3%-5.0pp | 11.9%-4.6pp | |
| Operating margin | 2.5%-1.1pp | 2.5%-1.9pp | 2.1%-3.0pp | 2.9%-3.3pp | 3.5%-3.1pp | |
| Net margin | 0.9%— | 0.7%— | —— | —— | —— | |
| EBITDA margin | 4%-0.9pp | 3.9%-1.9pp | 3.4%-3.2pp | 4.1%-3.5pp | 4.9%-3.0pp | |
| Free cash flow margin | 4.6%— | 3.5%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 3.9%— | 3%— | —— | —— | —— | |
| Return on assets | 1.6%— | 1.3%— | —— | —— | —— | |
| Return on invested capital | 4.6%-1.1pp | 4.1%-3.2pp | 2.7%-6.1pp | 4.6%-5.9pp | 5.7%-4.3pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×+0.2× | 1.8×0.0× | 1.6×+0.2× | 1.8×+0.4× | 1.8×+0.4× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.4× | 1.4×-0.3× | 1.4×-0.5× | 1.6×-0.3× | 1.7×+0.2× | |
| Quick ratio | 1.3×-0.4× | 1.4×-0.3× | 1.4×-0.5× | 1.6×-0.3× | 1.7×+0.2× | |
| Cash ratio | 0.6×-0.1× | 0.7×-0.1× | 0.7×-0.4× | 0.7×-0.3× | 0.7×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 1.3×+0.7× | 1.4×+0.7× | 1.4×+0.7× | 0.6×-0.1× | 0.6×-0.1× | |
| Debt-to-assets | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.3×-0.1× | 0.3×0.0× | |
| Net debt / EBITDA | 4.2×+2.4× | 5.2×+3.7× | 6.4×+5.2× | 1.1×-0.2× | 1.8×+0.9× | |
| Interest coverage | 1.5×-1.0× | 1.6×-1.1× | 1.5×-1.4× | 2.2×-1.7× | 2.4×-2.3× | |
| Per Share | ||||||
| Book value per share | $16.31+6.9% | —— | $15.68+7.3% | $15.47+9.4% | $15.26+11.4% | |
| Valuation | ||||||
| Market capitalization | $1.36B-3.0% | $1.24B-13.6% | $1.31B-52.6% | $1.23B-36.5% | $1.41B-29.5% | |
| Enterprise value | $1.95B+22.0% | $1.89B+16.6% | $1.93B-33.0% | $1.34B-35.9% | $1.6B-23.6% | |
| Price / earnings | 45.1×— | 55.3×— | —— | —— | —— | |
| Price / sales | 0.4×-0.2× | 0.4×-0.3× | 0.5×-1.2× | 0.5×-0.7× | 0.6×-0.7× | |
| Price / book | 1.7×-0.2× | 1.6×-0.4× | 1.7×-2.2× | 1.6×-1.2× | 1.9×-1.2× | |
| EV / EBITDA | 13.8×-0.8× | 15.2×+1.4× | 19.7×-5.8× | 13.5×-3.8× | 14.6×-3.6× | |
| EV / sales | 0.6×-0.2× | 0.6×-0.2× | 0.7×-1.0× | 0.6×-0.8× | 0.7×-0.7× | |
| Free cash flow yield | 11.8%— | 8.9%— | —— | —— | —— | |
| Earnings yield | 2.2%— | 1.8%— | —— | —— | —— | |
| Dividend yield | 0.2%-0.5pp | 0.6%+0.4pp | 0.6%-1.6pp | 0.7%-2.6pp | 0.7%-2.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Astrana Health's profit margins?
- Astrana Health (ASTH) runs a 10.7% gross margin and a 2.5% operating margin, with a 0.9% net margin.
- Where do Astrana Health's ratios come from?
- Every ratio is computed from Astrana Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
